[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"ketamine-adverse-reaction\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:ketamine-adverse-reaction":27},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":4,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":29,"lastUpdatePostDateStruct":30,"startDateStruct":33,"completionDateStruct":35,"leadSponsor":37,"locationsCount":5},"100400115","phase-4-evaluation-of-ketamine-as-sedative-agent-in-endoscopic-retrograde-cholangiopancreatography-ercp-100400115",false,"NCT04490031","Evaluation of Ketamine as Sedative Agent in Endoscopic Retrograde Cholangiopancreatography (ERCP)","Randomized Control Study Evaluating Ketamine as Sedative Agent in Endoscopic Retrograde Cholangiopancreatography (ERCP)","Inclusion Criteria:\n\n* Malaysian citizens of who is able to give valid consent\n* Patient planned for ERCP (either emergency or elective)\n\nExclusion Criteria:\n\n* Known hypersensitivity towards Ketamine or Midazolam\n* Patient refusal to participate or unable to give consent\n* Increased intracranial pressure, acute stroke (\\\u003C3 months), intracranial haemorrhage (\\\u003C3 months)\n* Uncontrolled hypertension (BP\\>160\u002F100) and tachycardia (Heart rate \\>120)\n* Acute myocardial infarction, acute coronary syndrome (\\\u003C3 months)\n* Tachyarrythmia\n* Pregnancy\n* IVDU or substance abuse patient\n* Patient with history of hallucination\n* Child's Pugh Class C",true,"ALL","16 Years",{"count":20,"type":21},140,"ESTIMATED","INTERVENTIONAL",[24],"PHASE4","This is a study evaluating the usage of Ketamine as sedative agent in ERCP. The usage of Ketamine will be compared to the standard sedation in our center, which is Midazolam in combination with Pethidine as analgesia.",[27],"Ketamine Adverse Reaction","RECRUITING","2020-07-24",{"date":31,"type":32},"2020-07-28","ACTUAL",{"date":34,"type":32},"2020-03-01",{"date":36,"type":21},"2021-04-30",{"name":38,"class":39},"Universiti Kebangsaan Malaysia Medical Centre","OTHER"]